Exciting news for Gelomics as they announce their recent funding round which raised an impressive $2,200,000. Gelomics is revolutionizing the field of biotechnology with their photocrosslinkable extracellular matrix kits that boast tunable mechanical properties, ideal for 3D cell and organoid culture, tissue engineering, and bioprinting. This substantial funding will be instrumental in furthering Gelomics' innovative research and development efforts, helping to expand their product line and accelerate their mission of advancing cutting-edge technologies in the biotech sector. With this infusion of capital, Gelomics is well-positioned to continue making significant strides in the field of tissue engineering and paving the way for groundbreaking discoveries that have the potential to transform the healthcare industry.
Breaking News: Gelomics Secures $2.2 Million in Pre-Seed Funding to Revolutionize 3D Cell Culture and Bioprinting
Recently funded 路 $2.2M Pre-seedBiotechnology
Get the full Gelomics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Dognosis India | Pre-seed | $1.5M | today |
| 2 | Dognosis India | Pre-seed | $1.5M | today |
